| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.1B | $0.1B | $0.2B | — | — | — | — | — |
| Net Income | $2.2B | $1.9B | $2.1B | $2.2B | $2.5B | $1.1B | $1.6B | $1.8B |
| EPS (Basic) | $2.31 | $1.94 | $2.11 | $2.29 | $2.51 | $1.03 | $1.51 | $1.55 |
| EPS (Diluted) | $2.30 | $1.93 | $2.11 | $2.28 | $2.49 | $1.03 | $1.50 | $1.54 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $158.8B | $157.3B | $152.2B | $155.2B | $162.9B | $147.4B | $126.2B | $125.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $3.5B |
| Total Liabilities | $139.7B | $139.4B | $134.7B | $139.3B | $144.6B | $129.3B | $109.9B | $110.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $19.0B | $17.9B | $17.4B | $15.9B | $18.3B | $18.1B | $16.3B | $15.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.2B | $1.6B | $2.3B | $3.1B | $3.0B | $2.3B | $2.6B | $2.3B |
| Investing Cash Flow | $-1.4B | $-0.3B | $-1.6B | $-12.9B | $-2.9B | $-4.9B | $0.5B | $-3.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.6B | $2.6B | $-5.1B | $-8.3B | $11.3B | $16.4B | $-2.5B | $0.3B |